The first Enzo Biochem trade was made in Q2 2013.
Since then Ken Griffin bought shares 28 more times and sold shares on 38 occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -7.33 Thousand shares
Q4 2023
Avg closing price
$1.33
Price range
$1.21
-
$1.44
Increased shares by 21.3% (+1.29 Thousand shares)
Q3 2023
Avg closing price
$1.51
Price range
$1.30
-
$1.87
Sold 73.6% shares (-16.8 Thousand shares)
Q2 2023
Avg closing price
$2.31
Price range
$1.84
-
$2.66
Sold 63.5% shares (-39.9 Thousand shares)
Q1 2023
Avg closing price
$1.47
Price range
$1.00
-
$2.51
Increased shares by 245.1% (+44.6 Thousand shares)
Q4 2022
Avg closing price
$1.95
Price range
$1.16
-
$2.42
Sold 36.1% shares (-10.3 Thousand shares)
Q3 2022
Avg closing price
$2.42
Price range
$2.10
-
$2.73
Increased shares by 171.0% (+18 Thousand shares)
Q2 2022
Avg closing price
$2.47
Price range
$2.00
-
$3.00
Sold 28.0% shares (-4.08 Thousand shares)
Q1 2022
Avg closing price
$3.21
Price range
$2.90
-
$3.47
Sold 73.5% shares (-40.4 Thousand shares)
Q4 2021
Avg closing price
$3.41
Price range
$3.17
-
$4.09
Sold 25.6% shares (-18.9 Thousand shares)
Q3 2021
Avg closing price
$3.34
Price range
$3.01
-
$3.77
Increased shares by 64.7% (+29 Thousand shares)
Q2 2021
Avg closing price
$3.15
Price range
$2.86
-
$3.61
Sold 12.2% shares (-6.25 Thousand shares)
Q1 2021
Avg closing price
$3.11
Price range
$2.61
-
$4.08
New holding (+51 Thousand shares)
Q3 2020
Avg closing price
$2.38
Price range
$2.02
-
$3.02
Sold -98.7 Thousand shares
Q2 2020
Avg closing price
$2.57
Price range
$2.12
-
$3.22
Increased shares by 51.9% (+33.7 Thousand shares)
Q1 2020
Avg closing price
$2.46
Price range
$1.82
-
$3.87
Sold 45.2% shares (-53.5 Thousand shares)
Q4 2019
Avg closing price
$2.99
Price range
$2.57
-
$3.68
Increased shares by 36.7% (+31.8 Thousand shares)
Q3 2019
Avg closing price
$3.54
Price range
$3.01
-
$4.00
Increased shares by 50.1% (+28.9 Thousand shares)
Q2 2019